Danyang Li – Trademark Portfolio

Entity Type: 01

Danyang Li holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered and 7 are pending. Notable registered marks include HILUHIDI. The owner is based in Shanxi Province.

Room 168, Bai Village

Wan'an Town, Hongdong County

Shanxi Province 041600 , CN

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Danyang Li's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (6 filings)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Danyang Li have?

Danyang Li has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 pending.

What trademark classes does Danyang Li file in?

Danyang Li files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Danyang Li's most well-known trademarks?

Danyang Li's registered trademark portfolio includes well-known marks such as HILUHIDI. These are among 1 currently registered trademark in the portfolio.

What is Danyang Li's trademark registration success rate?

Danyang Li has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 7 applications are pending review.